• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎严重程度与呼吸道微生物群的分类学变化有关。

Pneumonia Severity Is Associated with Taxonomic Shifts in the Respiratory Microbiota.

作者信息

Del Prete Valentina, Piazzesi Antonia, Scanu Matteo, Toto Francesca, Pane Stefania, Berrilli Federica, Paterno Giovangiacinto, Putignani Lorenza, di Cave David

机构信息

Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

Management and Diagnostic Innovations & Clinical Pathways Research Area, Unit of Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00144 Rome, Italy.

出版信息

Pathogens. 2025 Jan 16;14(1):82. doi: 10.3390/pathogens14010082.

DOI:10.3390/pathogens14010082
PMID:39861043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11768410/
Abstract

Pneumonia caused by infection (PCP) is a potentially life-threatening illness, particularly affecting the immunocompromised. The past two decades have shown an increase in PCP incidence; however, the underlying factors that promote disease severity and fatality have yet to be fully elucidated. Recent evidence suggests that the microbiota of the respiratory tract may play a role in stimulating or repressing pulmonary inflammation, as well as the progression of both bacterial and viral pneumonia. Here, we employed 16S rRNA metataxonomic sequencing to profile the respiratory microbiota of patients with mild-moderate and severe PCP. Our results show that the upper and lower airways of PCP patients have bacterial profiles which have been associated with a pro-inflammatory response. Furthermore, we find that severe PCP is associated with lower bacterial diversity and an increase in and a decrease in . Functionally, severe PCP was associated with a decrease in metabolic pathways of molecules with anti-inflammatory and antimicrobial properties. To our knowledge, this is the first study showing an association of PCP severity with shifts in the respiratory microbiome and may provide some insight into which patients are more susceptible to the more severe manifestations of the disease.

摘要

由感染引起的肺炎(PCP)是一种潜在的危及生命的疾病,尤其会影响免疫功能低下者。在过去二十年中,PCP的发病率有所上升;然而,促进疾病严重程度和死亡率的潜在因素尚未完全阐明。最近的证据表明,呼吸道微生物群可能在刺激或抑制肺部炎症以及细菌性和病毒性肺炎的进展中发挥作用。在这里,我们采用16S rRNA宏分类测序来分析轻度至中度和重度PCP患者的呼吸道微生物群。我们的结果表明,PCP患者的上呼吸道和下呼吸道具有与促炎反应相关的细菌谱。此外,我们发现重度PCP与较低的细菌多样性以及[此处原文缺失具体内容]的增加和[此处原文缺失具体内容]的减少有关。在功能上,重度PCP与具有抗炎和抗菌特性的分子的代谢途径减少有关。据我们所知,这是第一项显示PCP严重程度与呼吸道微生物群变化之间存在关联的研究,可能为哪些患者更容易出现该疾病的更严重表现提供一些见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/f69b52aeeb4d/pathogens-14-00082-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/075e100999f0/pathogens-14-00082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/acb614d15a00/pathogens-14-00082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/fa9d5f84a7a7/pathogens-14-00082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/957f8ab7bb6b/pathogens-14-00082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/0e8cbe60f9b0/pathogens-14-00082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/c648bd613045/pathogens-14-00082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/f0c305d98594/pathogens-14-00082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/f69b52aeeb4d/pathogens-14-00082-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/075e100999f0/pathogens-14-00082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/acb614d15a00/pathogens-14-00082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/fa9d5f84a7a7/pathogens-14-00082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/957f8ab7bb6b/pathogens-14-00082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/0e8cbe60f9b0/pathogens-14-00082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/c648bd613045/pathogens-14-00082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/f0c305d98594/pathogens-14-00082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4123/11768410/f69b52aeeb4d/pathogens-14-00082-g008.jpg

相似文献

1
Pneumonia Severity Is Associated with Taxonomic Shifts in the Respiratory Microbiota.肺炎严重程度与呼吸道微生物群的分类学变化有关。
Pathogens. 2025 Jan 16;14(1):82. doi: 10.3390/pathogens14010082.
2
Microbial communities in the respiratory tract of patients with interstitial lung disease.间质性肺疾病患者呼吸道中的微生物群落。
Thorax. 2013 Dec;68(12):1150-6. doi: 10.1136/thoraxjnl-2012-202917. Epub 2013 Aug 14.
3
Alterations in the gut microbiota of AIDS patients with pneumocystis pneumonia and correlations with the lung microbiota.艾滋病患者肺囊虫肺炎的肠道微生物群改变及其与肺部微生物群的相关性。
Front Cell Infect Microbiol. 2022 Oct 21;12:1033427. doi: 10.3389/fcimb.2022.1033427. eCollection 2022.
4
The lung microbiome in patients with pneumocystosis.肺微生物组在肺囊虫病患者中的研究。
BMC Pulm Med. 2017 Dec 4;17(1):170. doi: 10.1186/s12890-017-0512-5.
5
Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.半定量实时 PCR 区分 HIV 阴性免疫抑制患者异质人群中的肺孢子菌肺炎与定植。
Microbiol Spectr. 2021 Sep 3;9(1):e0002621. doi: 10.1128/Spectrum.00026-21. Epub 2021 Aug 4.
6
Pneumocystis jirovecii is a potential pivotal ecological driver contributing to shifts in microbial equilibrium during the early-life lower airway microbiome assembly.耶氏肺孢子菌是一种潜在的关键生态驱动因素,在生命早期下呼吸道微生物群组装过程中促成微生物平衡的转变。
Commun Biol. 2025 Apr 15;8(1):609. doi: 10.1038/s42003-025-07810-9.
7
Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study.实时 PCR 提高疑似肺孢子菌肺炎患儿上下呼吸道标本中肺孢子菌的检出率:一项前瞻性研究。
BMC Infect Dis. 2011 Nov 28;11:329. doi: 10.1186/1471-2334-11-329.
8
Search for Pneumocystis carinii DNA in upper and lower respiratory tract of humans.在人类的上、下呼吸道中寻找卡氏肺孢子虫DNA。
Diagn Microbiol Infect Dis. 2000 Jul;37(3):161-4. doi: 10.1016/s0732-8893(00)00146-2.
9
Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.肺孢子菌聚合酶链反应及血液(1→3)-β-D-葡聚糖检测对疑似耶氏肺孢子菌肺炎患者生存情况的预测价值
J Infect Chemother. 2014 Feb;20(2):109-14. doi: 10.1016/j.jiac.2013.09.004. Epub 2013 Dec 11.
10
[Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].[对医源性免疫抑制和免疫功能正常患者中耶氏肺孢子菌肺炎及定植情况的调查]
Mikrobiyol Bul. 2015 Apr;49(2):221-30. doi: 10.5578/mb.9344.

本文引用的文献

1
Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.HIV感染者中耶氏肺孢子菌肺炎治疗方案的疗效和安全性比较:一项随机对照试验的系统评价和网状荟萃分析
Clin Microbiol Infect. 2025 May;31(5):713-723. doi: 10.1016/j.cmi.2024.12.024. Epub 2024 Dec 26.
2
Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia.肺移植受者肺囊虫肺炎的肺微生物组改变。
Respir Res. 2024 Mar 14;25(1):125. doi: 10.1186/s12931-024-02755-9.
3
Lung microbiome: new insights into the pathogenesis of respiratory diseases.
肺部微生物组:呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
4
The microbiome and the gut-lung axis in tuberculosis: interplay in the course of disease and treatment.结核病中的微生物组与肠-肺轴:疾病进程与治疗中的相互作用
Front Microbiol. 2023 Oct 31;14:1237998. doi: 10.3389/fmicb.2023.1237998. eCollection 2023.
5
Three sesquiterpene lactones suppress lung adenocarcinoma by blocking TMEM16A-mediated Ca-activated Cl channels.三种倍半萜内酯通过阻断TMEM16A介导的钙激活氯通道来抑制肺腺癌。
Korean J Physiol Pharmacol. 2023 Nov 1;27(6):521-531. doi: 10.4196/kjpp.2023.27.6.521.
6
Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia.入住重症急性细菌性和病毒性肺炎患者的肺部微生物组。
Sci Rep. 2023 Oct 18;13(1):17724. doi: 10.1038/s41598-023-45007-4.
7
Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis.空间代谢组学揭示糖原是肺纤维化的可行治疗靶点。
Nat Commun. 2023 May 13;14(1):2759. doi: 10.1038/s41467-023-38437-1.
8
Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England.肺孢子菌肺炎发病率上升:英国一项基于人群水平的描述性生态学研究。
J Infect. 2023 Apr;86(4):385-390. doi: 10.1016/j.jinf.2023.02.014. Epub 2023 Feb 10.
9
The dynamic lung microbiome in health and disease.健康与疾病中的动态肺部微生物组。
Nat Rev Microbiol. 2023 Apr;21(4):222-235. doi: 10.1038/s41579-022-00821-x. Epub 2022 Nov 16.
10
Fungal microbiota dynamics and its geographic, age and gender variability in patients with cystic fibrosis.囊性纤维化患者真菌微生物群的动态变化及其地理、年龄和性别差异
Clin Microbiol Infect. 2023 Apr;29(4):539.e1-539.e7. doi: 10.1016/j.cmi.2022.11.001. Epub 2022 Nov 10.